Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 3/20 | 0.30 |
| ▸ | CA1 | P00915 | 3/20 | 0.30 |
| ▸ | CA2 | P00918 | 3/20 | 0.30 |
| ▸ | CA7 | P43166 | 3/20 | 0.30 |
| ▸ | CA9 | Q16790 | 3/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | PGD | P52209 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL27575429 | 1.00 | TSHR (0.50) | TSHRTP53HCAR2NFKB1CYP2C19 | |
| SCHEMBL1336756 | 0.89 | TSHR (0.50) | TSHRTP53HCAR2CA12CA1 | |
| SCHEMBL1338978 | 0.89 | TSHR (0.50) | TSHRTP53HCAR2CA12CA1 | |
| SCHEMBL571478 | 0.89 | TSHR (0.50) | TSHRTP53HCAR2CA12CA1 | |
| SCHEMBL8636434 | 0.89 | TSHR (0.50) | TSHRTP53HCAR2CA12CA1 | |
| SCHEMBL10634108 | 0.86 | PDE4A (0.41) | TSHRTP53HCAR2 | |
| SCHEMBL31649104 | 0.86 | PDE4A (0.41) | TSHRTP53HCAR2 | |
| SCHEMBL981017 | 0.83 | TSHR (0.48) | TSHRTP53NFKB1CYP2C19 | |
| Ethylene Glycol SCHEMBL28051222 | 0.80 | TSHR (0.42) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL7438737 | 0.80 | TSHR (0.42) | TSHRHCAR2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119104658-A | Method for detecting valicarb-isopropyl tartrate genotoxic impurity D | 山东百诺医药股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-117838769-A | Combined suppository of valicarb-isopropyl tartrate and houttuynia cordata and preparation method thereof | 湖北广济医药科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117715910-A | Nitrosamine impurity, valicarb pharmaceutical composition capable of reducing nitrosamine impurity generation, and preparation and application thereof | 威智医药股份有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-117442575-A | Vanilla pharmaceutical composition and preparation and application thereof | 山东威智中科药业有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117026673-A | Irradiation crosslinked degradable coated paper and preparation method thereof | 中广核俊尔（上海）新材料有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-116338025-A | Method for measuring N-nitrosovalinamide by liquid chromatography-mass spectrometer | 江苏嘉逸医药有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-113980020-B | Preparation method of valicarb tartrate crystal form | 浙江车头制药股份有限公司 | 2023-05-09 | — | — | CN | claimed |
| EP-2738164-A1 | Synthesis of an intermediate of an antiviral compound | Dipharma Francis S.r.l. (IT) | 2014-06-04 | — | — | EP | claimed |
| US-20140148574-A1 | SYNTHESIS OF AN INTERMEDIATE OF AN ANTIVIRAL COMPOUND | DIPHARMA FRANCIS S.R.L. (IT) | 2014-05-29 | — | — | US | claimed |
| CN-121476463-A | Method for detecting sample by adopting solid phase extraction to treat related substances of valicarb-isopropyl tartrate preparation | 江苏嘉逸医药有限公司 | 2026-02-06 | — | — | CN | disclosed |
| CN-121476463-A | Method for detecting sample by adopting solid phase extraction to treat related substances of valicarb-isopropyl tartrate preparation | 江苏嘉逸医药有限公司 | 2026-02-06 | — | — | CN | disclosed |
| CN-115707687-B | Related impurity compound of valicarb-isopropyl tartrate, and preparation, application and detection methods thereof | 威智医药股份有限公司 | 2025-07-11 | — | — | CN | disclosed |
| CN-115707687-B | Related impurity compound of valicarb-isopropyl tartrate, and preparation, application and detection methods thereof | 威智医药股份有限公司 | 2025-07-11 | — | — | CN | disclosed |
| CN-115707688-B | Impurity compound in raw material for preparing valicarb-isopropyl tartrate, and preparation, application and detection methods thereof | 威智医药股份有限公司 | 2025-05-16 | — | — | CN | disclosed |
| US-20070275022-A1 | Cosmetic Hair Preparation | LION CORPORATION (JP) | 2007-11-29 | — | — | US | disclosed |
| CN-1222906-A | Urea/ureido functional polymerizable monomers | CYTEC TECH CORP (US) | 1999-07-14 | — | — | CN | disclosed |
| EP-0298756-B1 | Optically active allyl alcohol and process for producing leucotriene B4 using thereof | NISSAN CHEMICAL IND LTD (JP) | 1997-11-26 | — | — | EP | disclosed |
| US-5073646-A | Chemical intermediates, microbiocides | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 1991-12-17 | — | — | US | disclosed |
| EP-0298756-A2 | Optically active allyl alcohol and process for producing leucotriene B4 using thereof | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1989-01-11 | — | — | EP | disclosed |
| US-4005189-A | Process of suppressing odors employing deodorants containing esters of aliphatic hydroxycarboxylic acids | HENKEL & CIE G.M.B.H. (DT) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070275022-A1 | Cosmetic Hair Preparation | CUTA, H1-10, PUF60 | TSHR 3396/4885TP53 1184/4885HCAR2 21/4885 |
| US-20140148574-A1 | SYNTHESIS OF AN INTERMEDIATE OF AN ANTIVIRAL COMPOUND | ZC3HAV1, PREP, EIF2AK2 | TSHR 4732/4885TP53 1407/4885HCAR2 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.